Can I read Hofmann-2020-Selective and Potent CDK8 - 19 Inhi on EtoBox?

Hofmann-2020-Selective and Potent CDK8 - 19 Inhi by shuliu.5798 is a document available to read on EtoBox.

What is Hofmann-2020-Selective and Potent CDK8 - 19 Inhi about?

The study investigates the role of selective CDK8/19 inhibitors in enhancing natural killer (NK) cell activity to improve tumor surveillance and promote antitumor immunity. The combination of the CDK8/19 inhibitor BI-1347 with the SMAC mimetic BI-8382 significantly increases NK cell cytotoxicity and survival rates in murine models of breast cancer and melanoma. These findings suggest that CDK8/19 inhibitors can be effectively used in cancer immunotherapy by augmenting NK cell function rather than directly t

Author

shuliu.5798

Language

EN